N127100-25mgNVP-LCQ195
面议
- 阿拉丁
- 生产商
- N127100-25mg
- 现货
- 全国
规格 |
---|
耗材描述
- 分子式 C17H19Cl2N5O4S
- 分子量460.33
属性
溶解性 | DMSO |
存贮条件 | 储存温度-20°C |
描述
产品介绍 | NVP-LCQ195 (AT9311; LCQ195)是CDK杂环类抑制剂,对CDK1,CDK2,CDK3和CDK5的IC50为1-42 nM。 |
生化机理 | NVP-LCQ195 (AT9311; LCQ195) is a small molecule heterocyclic compound which inhibits CDK1, CDK2 and CDK5, as well as CDK3 and CDK9. Cell cycle regulators, such as cyclin-dependent kinases (CDKs), are appealing targets for multiple myeloma (MM) therapy given the increased proliferative rates of tumour cells in advanced versus early stages of MM. NVP-LCQ195 induced cell cycle arrest and eventual apoptotic cell death of MM cells, even at sub-μmol/l concentrations, spared non-malignant cells, and overcame the protection conferred to MM cells by stroma or cytokines of the bone marrow milieu. |
别名 | LCQ-195;AT-9311;NVP LCQ195;LCQ 195;AT9311;AT 9311;4-(2,6-二氯苯甲酰基氨基)-1H-吡唑-3-羧酸 N-[1-(甲基磺酰基)哌啶-4-基]酰胺;LCQ-195;AT-9311;NVP LCQ195;LCQ 195;AT9311;AT 9311;4-(2,6-Dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid N-[1-(methylsulfonyl)piperidin-4-yl]amide |
猜你喜欢
感兴趣产品